Crystalline modification of mixtures of a nickel-quencher and a benzophenone and process for its preparation

ABSTRACT

Crystalline modification of mixtures comprising (a) a nickel-quencher corresponding to [2,2′-thio-bis(4-t-octylphenolate)-n-butylamine Nickel (II)] and (b) a 2-hydroxy-4-alkyloxybenzophenone corresponding to 2-hydroxy-4-n-octyloxybenzophenone wherein it has two diffraction lines at angles 2{acute over (ø)}=6.291 and 2{acute over (ø)}=6.888 in the X-Ray diffraction spectrum from powders. The said crystalline modification can be used as a light stabilizer for agricultural films based on polyolefins or polyolefinic copolymers.

The present invention relates to a crystalline modification of mixtures of a nickel-quencher and a benzophenone.

More specifically, the present invention relates to a crystalline modification of mixtures of a nickel-quencher corresponding to [2,2′-thiobis(4-t-octylphenolate)-n-butylamine Nickel (II)] and a 2-hydroxy-4-alkyloxybenzophenone corresponding to 2-hydroxy-4-n-octyloxybenzophenone, a process for its preparation and its use as a light stabilizer for agricultural films based on polyolefins or polyolefinic copolymers.

The present invention also relates to agricultural films based on polyolefins or polyolefinic copolymers stabilized with the above crystalline modification and greenhouses covered with these films.

Nickel-quenchers are at present sold in fine powder form and their use causes problems of environmental pollution, health and the safety of the operators in the feeding and handling phase.

A benzophenone is also generally used in the stabilization of agricultural films, together with nickel-quenchers.

Conventional methods for obtaining a physical form of nickel-quencher with a low powder content (for example, compaction of the powders under pressure) tested on both the nickel-quencher alone, and on mixtures of nickel-quenchers and benzophenones, have proved to be inapplicable or have not given satisfactory results.

The Applicant has now found a crystalline modification of mixtures of a nickel-quencher and a benzophenone capable of overcoming the drawbacks of the known art.

The present invention therefore relates to a crystalline modification of mixtures comprising:

(a) a nickel-quencher corresponding to [2,2′-thiobis(4-t-octyl-phenolate)-n-butylamine Nickel (II)] having formula (I):

(b) a 2-hydroxy-4-alkyloxybenzophenone corresponding to the 2-hydroxy-4-n-octyloxybenzophenone having formula (II):

 characterized in that it has two diffraction lines at angles 2θ=6.291 and 2θ=6.888 in the X-Ray diffraction spectrum from powders.

The X-Ray diffraction spectrum from powders is carried out using Cu—K_(α) radiation (λ=1.54178).

In the crystalline modification of the present invention, the nickel-quencher (a) having formula (I) and the benzophenone (b) having formula (II), are used in a ratio ranging from 0.4 to 3, preferably in a ratio ranging from 1 to 2.

The nickel-quencher (a) having formula (I) is known under the following trade-names: Cyasorb UV 1084 of Cytec, or Chimassorb N-705 of Ciba.

The benzophenone (b) having formula (II) is known under the following trade-names: Lowilite 22 of Great Lakes, Chimassorb 81 of Ciba, or Cyasorb UV 531 of Cytec.

The crystalline modification of the present invention can be obtained, for example, with a process comprising the extrusion of a mixture of powders of the two components, operating at such a temperature that only a small part of the benzophenone (b), having a melting point of 47° C.-50° C., melts and dissolves only a small part of the nickel-quencher (a), having a melting point>260° C.

A solid “spaghetto” is thus obtained which, after appropriate cooling, can be granulated by cutting at the head of the extruder or by subsequent fragmentation.

The molten part of the benzophenone (b) and the part of the nickel-quencher (a) dissolved therein, on resolidifying, act as a binder for the remaining components, benzophenone (b) and nickel-quencher (a), which are still in powder form: in this way the solid “spaghetto” is obtained, which is subsequently cooled and cut as described above.

The nickel-quencher (a) and benzophenone (b) powders and the granules obtained by extrusion as described above, are subjected to X-Ray diffraction and the spectra obtained are indicated in the following figures:

FIG. 1: X-Ray diffraction spectrum from powders of the nickel-quencher (a) in powder form;

FIG. 2: X-Ray diffraction spectrum from powders of benzophenone (b) in powder form;

FIG. 3: X-Ray diffraction spectrum from powders of the physical mixture of nickel-quencher (a) and benzophenone (b) powders;

FIG. 4: X-Ray diffraction spectrum from powders of the granules obtained by extrusion, as described above, from the mixture of nickel-quencher (a) and benzophenone (b) powders.

FIG. 5: a histogram illustrating stabilization as a function of concentration.

As can be observed, FIG. 4 shows two diffraction lines at angles 2θ=6.291 and 2θ=6.888 in the X-Ray diffraction spectrum from powders which are not present in the X-Ray diffraction spectrum from powders of the nickel-quencher (a) and benzophenone (b) alone (FIGS. 1 and 2) and their physical mixture (FIG. 3).

As already mentioned above, the crystalline modification of the present invention is useful as a light stabilizer for agricultural films based on polyolefins and polyolefinic copolymers.

Polyolefins and polyolefinic copolymers which can be used for the purpose are:

(1) polymers of mono-olefins and diolefins such as, for example, polypropylene, polyisobutylene, polybut-1-ene, poly-4-methylpent-1-ene, polyisoprene or polybutadiene; as well as polymers of cyclo-olefins such as, for example, cyclopentene or norbornene; polyethylene (which can be optionally cross-linked) such as, for example, high density polyethylene (HDPE), low density polyethylene (LDPE) linear low density polyethylene (LLDPE), branched low density polyethylene (BLDPE).

Polyolefins such as, for example the mono-olefins mentioned in the above paragraph, preferably polyethylene and polypropylene, can be prepared with various methods known in literature, preferably using the following methods:

(a) radicalic polymerization (generally carried out at a high pressure and high temperature);

(b) catalytic polymerization using a catalyst which normally contains one or more metals of groups IVb, Vb, VIb or VIII of the Periodic Table. These metals generally have one or more ligands such as, for example, oxides, halides, alcoholates, esters, ethers, amines, alkyls, alkenyls and/or aryls which can be π- or σ-co-ordinated. These metal complexes can be in free form or supported on substrates such as, for example activated magnesium chloride, titanium(III) chloride, alumina or silicon oxide. These catalysts can be soluble or insoluble in the polymerization medium. The catalysts can be used alone or in the presence of other activators such as, for example, metal alkyls, metal hydrides, halides of metal alkyls, oxides of metal alkyls or metal alkyloxanes, these metals being elements belonging to groups Ia, IIa and/or IIIa of the Periodic Table. The activators can be conveniently modified with other ester, ether, amine or silyl-ether groups. These catalytic systems are usually called Phillips, Standard Oil Indiana, Ziegler (-Natta), TNZ (Du-Pont), metallocene or “single site catalyst” (SSC).

(2) Mixtures of the polymers described under point (1) such as, for example, mixtures of polypropylene with polyisobutylene; mixtures of polypropylene with polyethylene (for example, PP/HDPE, PP/LDPE); mixtures of different types of polyethylene (for example, LDPE/HDPE).

(3) Copolymers of mono-olefins and diolefins with each other or with other vinyl monomers such as, for example, ethylene-propylene copolymers, linear low density polyethylene (LLDPE) and its mixtures with low density polyethylene (LDPE), propylene/but-1-ene copolymers, propylene/isobutylene copolymers, ethylene/but-1-ene copolymers, ethylene/hexene copolymers, ethylene/methylpentene copolymers, ethylene/heptene copolymers, ethylene/octene copolymers, propylene/butadiene copolymers, isobutylene/isoprene copolymers, ethylene/alkyl acrylate copolymers, ethylene/alkyl methacrylate copolymers, ethylene/vinyl acetate copolymers and their copolymers with carbon monoxide or ethylene/acrylic acid copolymers and their salts (ionomers) as well as terpolymers of ethylene with polypropylene and a diene such as, for example, hexadiene, dicyclopentadiene or ethylidene-norbornene; and mixtures of these copolymers with each other or with the polymers cited in paragraph (1) such as, for example, polypropylene/ethylene-propylene copolymers, LDPE/ethylene-vinylacetate (EVA) copolymers, LDPE/ethylene-acrylic acid (EAA) copolymers, LLDPE/EVA, LLDPE/EAA, and alternating or random polyalkylene/carbon monoxide copolymers and their mixtures with other polymers such as, for example, polyamides.

Preferred for the purpose are polymers of mono-olefins, preferably α-mono-olefins such as, for example, polypropylene, polyisobutylene, polybut-1-ene, poly-4-methylpent-1-ene, as well as polymers of cyclo-olefins, polyethylene (which can be optionally cross-linked) such as, for example, high density polyethylene (HDPE), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), branched low density polyethylene (BLDPE) and copolymers of these monomers with vinyl acetate. Even more preferred are polyethylene, ethylene/propylene copolymer, ethylene/vinyl acetate copolymer and polypropylene, in particular polyethylene, preferably low density polyethylene (LDPE).

A further object of the present invention relates to agricultural films based on polyolefins or polyolefinic copolymers containing an effective quantity of the crystalline modification described above.

The crystalline modification of the present invention can be used as such or combined with other stabilizers, in the above polymeric agricultural films.

The crystalline modification of the present invention is generally used in a quantity ranging from about 0.1% to about 2% by weight with respect to the weight of the films to be stabilized, preferably between about 0.2% and about 1%.

The crystalline modification of the present invention, optionally in the presence of other additives, can be easily incorporated into the polymers to be stabilized using the conventional techniques.

The resulting polymeric compositions can be transformed into films operating according to the conventional techniques.

The above films based on polyolefins or poly-olefinic copolymers, can contain metal oxides or hydroxides such as, for example, oxides of zinc, aluminum, calcium or magnesium, or hydroxides of zinc, aluminum or calcium, preferably zinc oxide (ZnO), zinc hydroxide [Zn(OH)₂], aluminum ortho- or meta-hydroxide [Al(OH)₃], aluminum α- or γ-oxide, magnesium oxide (MgO). Zinc oxides or hydroxides are preferred, zinc oxide is even more preferred.

The above metal oxides or hydroxides are generally added in a quantity ranging from 0.005% to 3% by weight with respect to the weight of the films to be stabilized, preferably between 0.005% and 1% by weight, even more preferably between 0.025% and 0.5% by weight.

In many cases, the above films contain a salt of a C₁-C₃₀ carboxylic acid, preferably a salt of a C₈-C₂₂ carboxylic acid, even more preferably a salt of a C₈-C₁₈ carboxylic acid.

Preferred films are those which contain one or more components selected from salts of earth-alkaline metals, zinc salts and aluminum salts of a C₁-C₃₀ carboxylic acid, hydrotalcites, and sterically hindered amines.

Films based on polyolefins or polyolefinic copolymers containing salts of a C₁-C₃₀ carboxylic acid are of greatest interest for the purpose. Metal carboxylates which can be optionally added are, mainly, salts of Al, Ba, Ca, Mg, Sr or Zn. Salts of Al, Ca, Mg or Zn, especially of C₁-C₁₈ carboxylic acids, are preferred. Calcium salts such as, for example, calcium stearate, are even more preferred.

The metal carboxylates are used in a quantity ranging from 0.05% to 2% by weight with respect to the weight of the films to be stabilized, preferably between 0.1% and 1% by weight.

The sterically hindered amines are added in a quantity ranging from about 0.01% to 5% by weight with respect to the weight of the films to be stabilized, preferably between 0.025% and 2% by weight, even more preferably between 0.05% and 1% by weight.

The films described above may advantageously contain a hydrotalcite. Hydrotalcites which can be used for the purpose are selected from those having the following general formula (III):

M²⁺ _(1−x)·M³⁺ _(x)·(OH)₂·(A^(n−))_(x/n)·pH₂O  (III)

wherein:

M²⁺ is Mg, Ca, Sr, Ba, Zn, Pb, Sn and/or Ni;

M³⁺ is Al, B or Bi;

A^(n−) is an anion of the valency n;

n is a number between 1 and 4 extremes included;

x is a number between 0 and 0.5 extremes included;

p is a number between 0 and 2 extremes included;

A is OH⁻, Cl⁻, Br⁻, I⁻, ClO₄ ⁻, HCO₃ ⁻, CH₃COO⁻, C₆H₅COO⁻, CO₃ ²⁻, SO₄ ²⁻, (COO)₂ ²⁻, (CHOHCOO)₂ ²⁻, (CHOH)₄CH₂OHCOO⁻, C₂H₄ (COO)₂ ²⁻, (CH₂COO)₂ ²⁻, CH₃CHOHCOO⁻, SiO₃ ²⁻, SiO₄ ⁴⁻, Fe (CN)₆ ³⁻, Fe (CN)₆ ⁴⁻, BO₃ ³⁻, PO₃ ³⁻ or HPO₄ ²⁻.

Preferred hydrotalcites having general formula (III) are those wherein M²⁺ is Ca²⁺, Mg²⁺ or a mixture of Mg²⁺ and Zn²⁺, A^(n−) is CO₃ ²⁻, BO₃ ³⁻ or PO₃ ³⁻, x is a number between 0 and 0.5 extremes included and p is a number between 0 and 2 extremes included.

Other hydrotalcites which can be advantageously used are those having general formula (IIIa)

M_(x) ²⁺Al₂(OH)_(2x+6nz)(A^(n−))₂·pH₂O  (IIIa)

wherein:

M²⁺ is Mg or Zn, preferably Mg;

A^(n−) is an anion selected from CO₃ ²⁻, (COO)₂ ²⁻, OH⁻ and S²⁻, wherein n is the valency of the anion.

p is a positive number, preferably between 0 and 5 extremes included, for example between 0.5 and 5 extremes included;

x is a positive number preferably between 2 and 6 extremes included;

z is a positive number less than 2.

Preferred hydrotalcites having general formula (IIIa) are those represented by the following formulae (IIIb)-(IIIh):

Al₂O₃·6MgO·CO₂·12H₂O  (IIIb);

Mg_(4.5)Al₂(OH)₁₃·CO₃·3.5H₂O  (IIIc);

4MgO·Al₂O₃·CO₂·9H₂O  (IIId);

4MgO·Al₂O₃·CO₂·6H₂O  (IIIe);

ZnO·3MgO·Al₂O₃·CO₂·8—9H₂O  (IIIf);

ZnO·3MgO·Al₂O₃·CO₂·5—6H₂O  (IIIg);

Mg_(4.5)Al₂(OH)₁₃·CO₃  (IIIh).

The hydrotalcites can be advantageously used in a quantity ranging from 0.01% to 5% by weight with respect to the weight of the films to be stabilized, preferably between 0.2% and 3% by weight.

Useful sterically hindered amines which can be added to the films described above, can be single compounds or mixtures of these compounds. In the case of mixtures, the quantities indicated above refer to the total quantity of sterically hindered amines used.

Sterically hindered amines refer to compounds containing one or more trivalent groups having general formula (IV):

wherein G is hydrogen or methyl and not more than one of the free valencies in the above general formula (IV) is saturated with a hydrogen and 2 or 3 of the free valencies represent bonds with carbon atoms or hetero-atoms.

Examples of the above sterically hindered amines are described, for example, in U.S. Pat. Nos. 4,086,204, 4,108,829, 4,263,434, 4,233,412, 4,288,593, 4,315,859, 4,321,374, 4,331,586, 4,413,093, 4,435,555, 4,477,615, 4,335,242, 4,376,836, 4,433,145, 4,459,395, 4,477,615, 4,533,688, 4,540,728, 4,547,548 and 4,740,544; in European patent applications EP 22,080, EP 29,522, EP 24,338, EP 42,554, EP 44,499, EP 70,386, EP 72,009, EP 75,849, EP 82,244, EP 94,048, EP 107,615, EP 402,889 and EP 357,223; and in German patent application DE 3,530,666; the texts of the above documents should be considered as forming an integrant part of the present description.

In many cases, the sterically hindered amines are cyclic, in particular they are compounds selected from polyalkylpiperidine derivatives containing at least one group having general formula (V):

wherein G is hydrogen or methyl, and G₁ and G₂ are hydrogen, methyl or, together, they are a substituent ═O; the polyalkylpiperidine groups having general formula (V) are preferably substituted in position 4 by one or two polar substituents or by a polar ring having a spiro structure.

Of particular importance are cyclic sterically hindered amines containing at least one group having general formula (V) wherein G is hydrogen and G₁ and G₂ are hydrogen or, together, are a substituent ═O.

In particular, derivatives of 2,2,6,6-tetramethylpiperidine are advantageously used.

Of particular importance is the use of compounds belonging to the group of polyalkylpiperidine carrying at least one group having general formula (V) in the molecule, selected from those listed below under points (a)-(i)

(a) Compounds Having General Formula (V ):

 wherein n is a number between 1 and 4 extremes included; G and Gi are, each independently, hydrogen or methyl; G₁₁ is hydrogen, a C₁-C₁₆ alkyl group, a C₃-C₈ alkenyl group, a C₃-C₈ alkinyl group, a C₇-C₁₂ aralalkyl group, a C₁-C₈ alkanoyl group, a C₃-C₅ alkenoyl group, a glycidyl group, a —CH₂CH(OH)—Z group wherein Z is hydrogen, methyl, or phenyl, G₁₁ preferably being hydrogen, a C₁-C₄ alkyl group, an allyl, a benzyl, an acetyl or an acryloyl; G₁₂, when n is 1, is hydrogen, a C₁-C₁₈ alkyl group which can be interrupted by one or more oxygen atoms, a cyanoethyl group, a benzyl, a glycidyl group, a monovalent radical of a carboxylic acid, of a carbamic acid or of an acid containing phosphorous, aliphatic, cycloaliphatic or araliphatic, unsaturated or aromatic, or a monovalent silyl radical, preferably a radical of an aliphatic carboxylic acid having from 2 to 18 carbon atoms, of a cycloaliphatic carboxylic acid having from 7 to 15 carbon atoms, of an α,β-unsaturated carboxylic acid having from 3 to 5 carbon atoms, of an aromatic carboxylic acid having from 7 to 15 carbon atoms, said carboxylic acids optionally substituted in the aliphatic, cycloaliphatic or aromatic part with 1-3 —COOZ₁₂ groups wherein Z₁₂ is hydrogen, a C₁-C₂₀ alkyl group, a C₃-C₁₂ alkenyl group, a C₅-C₇ cycloalkyl group, a phenyl or a benzyl; G₁₂, when n is 2, is a C₂-C₁₂ alkylene group, a C₄-C₂ alkenylene group, a xylylene group, a divalent radical of a dicarboxylic acid, of a dicarbamic acid or of an acid containing phosphorous, aliphatic, cycloaliphatic, araliphatic or aromatic, or a divalent silyl radical, preferably a radical of an aliphatic dicarboxylic acid having from 2 to 36 carbon atoms, of a cycloaliphatic or aromatic dicarboxylic acid having from 8 to 14 carbon atoms, of an aliphatic, cycloaliphatic or aromatic dicarbamic acid having from 8 to 14 carbon atoms, said dicarboxylic acids optionally substituted in the aliphatic, cycloaliphatic or aromatic part, with 1 or 2 —COOZ₁₂ groups wherein Z₁₂ has the same meanings described above; G₁₂, when n is 3, is a trivalent radical of an aliphatic, cycloaliphatic or aromatic tricarboxylic acid, optionally substituted in the aliphatic, cycloaliphatic or aromatic part, with a —COOZ₁₂ group wherein Z₁₂ has he same meanings described above, or of an aromatic tricarbamic acid or of an acid containing phosphorous, or it is a trivalent silyl radical; G₁₂, when n is 4, is a tetravalent radical of an aliphatic, cycloaliphatic or aromatic tetracarboxylic acid.

Radicals of tetracarboxylic acids comprise, in any case, radicals having the formula (—CO)_(n)R wherein n has the same meaning defined above and R can be easily deduced from the definition described above.

Examples of C₁-C₁₂ alkyl groups are: methyl, ethyl, n-propyl, n-butyl, sec-butyl, t-butyl, n-hexyl, n-octyl, 2-ethylhexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, etc.

Examples of G₁₁ and G₁₂ substituents, when they are a C₁-C₁₈ alkyl group, are, in addition to the groups described above: n-tridecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, etc.

Examples of the substituent G₁₁, when it is a C₃-C₈ alkenyl group, are: 1-propenyl, allyl, methallyl, 2-butenyl, 2-pentenyl, 2-hexenyl, 2-octenyl, 4-t-butyl-2-butenyl, etc.

When the substituent G₁₁ is a C₃-C₈ alkinyl group, it is preferably propargyl.

When the substituent G₁₁ is a C₇-C₁₂ aralalkyl group, it is in particular phenethyl, preferably benzyl.

Examples of the substituent G₁₁, when it is a C₁-C₈ alkanoyl group, are: formyl, propionyl, butyryl, octanoyl, preferably acetyl and, when it is a C₃-C₅ alkenoyl group, preferably acryloyl.

Examples of the substituent G₁₂, when it is a monovalent radical of a carboxylic acid, are radicals of the following acids: acetic, caproic, stearic, acrylic, methacrylic, benzoic, β-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic, etc.

Examples of the substituent G₁₂, when it is a monovalent silyl radical, are: a radical having the general formula —(C_(j)H_(2j))—Si(Z′)₂Z″ wherein j is an integer between 2 and 5 extremes included, and Z′ and Z″ are, each independently, a C₁-C₄ alkyl group or a C₁-C₄ alkoxyl group.

Examples of the substituent G₁₂, when it is a divalent radical of a dicarboxylic acid, are radicals of the following acids: malonic, succinic, glutaric, adipic, suberic, sebacic, maleic, itaconic, phthalic, dibutylmalonic, dibenzylmalonic, butyl(3,5-di-t-butyl-4-hydroxybenzyl)malonic, bicycloheptenedicarboxylic, etc.

Examples of the substituent G₁₂, when it is a trivalent radical of a tricarboxylic acid, are radicals of the following acids: trimellitic, citric, nitrilotriacetic, etc.

Examples of the substituent G₁₂ when it is a tetravalent radical of a tetracarboxylic acid, are radicals of the following acids: butane-1,2,3,4-tetracarboxylic, pyromellitic, etc.

Examples of the substituent G₁₂, when it is a divalent radical of a dicarbamic acid, are radicals of the following acids: hexamethylenedicarbamic, 2,4-to-luylenedicarbamic, etc.

Compounds having general formula (VI) are preferred, wherein G is hydrogen, G₁₁ is hydrogen or methyl, n is 2 and G₁₂ is a diacyl radical of an aliphatic dicarboxylic acid having from 4 to 12 carbon atoms.

Specific examples of polyalkylpiperidines having general formula (VI) are:

1) 4-hydroxy-2,2,6,6-tetramethylpiperidine;

2) 1-allyl-4-hydroxy-2,2,6,6-tetramethylpiperidine;

3) 1-benzyl-4-hydroxy-2,2,6,6-tetramethylpiperidine;

4) 1-(4-t-butyl-2-butenyl)-4-hydroxy-2,2,6,6-tetramethylpiperidine;

5) 4-stearyloxy-2,2,6,6-tetramethylpiperidine;

6) 1-ethyl-4-salicyloyloxy-2,2,6,6-tetramethylpiperidine;

7) 4-methacryloyloxy-1,2,2,6,6,-pentamethylpiperidine;

8) 1,2,2,6,6-pentamethylpiperidin-4-yl-β-(3,5-di-t-butyl-4-hydroxyphenyl)propionate;

9) di(1-benzyl-2,2,6,6-tetramethylpiperidin-4-yl)maleate;

10) di(2,2,6,6-tetramethylpiperidin-4-yl)succinate;

11) di(2,2,6,6-tetramethylpiperidin-4-yl)glutarate;

12) di(2,2,6,6-tetramethylpiperidin-4-yl)adipate;

13) di(2,2,6,6-tetramethylpiperidin-4-yl)sebacate;

14) di(1,2,2,6,6-pentamethylpiperidin-4-yl)sebacate;

15) di(1,2,3,6-tetramethyl-2,6-diethylpiperidin-4-yl)sebacate;

16) di(1-allyl-2,2,6,6-tetramethylpiperidin-4-yl)phthalate;

17) (1-acetyl-2,2,6,6-tetramethylpiperidin-4-yl)acetate;

18) ester of tri(2,2,6,6-tetramethylpiperidin-4-yl)trimellitic acid;

19) 1-acryloyl-4-benzyloxy-2,2,6,6-tetramethylpiperidilne;

20) di(2,2,6,6-tetramethylpiperidin-4-yl)diethylmalonate;

21) di(1,2,2,6,6-pentamethylpiperidin-4-yl)dibutylmalonate;

22) di(1,2,2,6,6-pentamethylpiperidin-4-yl)butyl-(3,5-di-tert-butyl-4-hydroxybenzyl)malonate;

23) hexane-1′,6′-bis(4-carbamoyloxy-1-n-butyl-2,2,6,6-tetramethylpiperidine);

24) toluene-2′,4′-bis(4-carbamoyloxy-1-n-propyl-2,2,-6,6-tetramethylpiperidine;

25) dimethyl-bis(2,2,6,6-tetramethylpiperidin-4-oxy)silane;

26) phenyl-tris(2,2,6,6-tetramethylpiperidin-4-oxy)silane;

27) tris(1-propyl-2,2,6,6-tetramethylpiperidin-4-yl)phosphite;

28) tris(1-propyl-2,2,6,6-tetramethylpiperidin-4-yl)phosphate;

29) bis(1,2,2,6,6,-pentamethylpiperidin-4-yl)phenylphosponate;

30) 4-hydroxy-1,2,2,6,6,-pentamethylpiperidine;

31) 4-hydroxy-N-hydroxyethyl-2,2,6,6,-tetramethylpiperidine;

32) 4-hydroxy-N-(2-hydroxypropyl)-2,2,6,6-tetramethylpiperidine;

33) 1-glycidyl-4-hydroxy-2,2,6,6-tetramethylpiperidine.

(b) Compounds Having General Formula (VII):

 wherein n is 1 or 2; G, G₁ and G₁₁ have the same meanings defined under point (a); G₁₃ is hydrogen, a C₁-C₁₂ alkyl group, a C₂-C₅ hydroxyalkyl group, a C₅-C₇ cycloalkyl group, a C₇-C₈ aralalkyl group, a C₂-C₈ alkanoyl group, a C₃-C₅ alkenoyl group, a benzoyl group, or a group having the following general formula:

 wherein G, G₁ and G₁₁ have the same meanings defined under point (a); G₁₄, when n is 1, is hydrogen, a C₁-C₁₈ alkyl group, a C₃-C₈ alkenyl group, a C₅-C₇ cycloalkyl group, a C₁-C₄ alkyl group substituted with a hydroxyl group, with a cyano group, with an alkoxycarbonyl group or with a carbamide group, a glycidyl group, a group having the formula —CH₂—CH(OH)—Z or having the formula —CONH—Z wherein Z is hydrogen, methyl or phenyl; G₁₄, when n is 2, is a C₂-C₁₂ alkylene group, a C₆-C₁₂ arylene group, a xylylene group, a group having the formula —CH₂—CH(OH)—CH₂— or having the formula —CH₂—CH(OH)—CH₂—O—D—O— wherein D is a C₂-C₁₀ alkylene group, a C₆-C₁₅ arylene group, a C₆-C₁₂ cycloalkylene group; or, on the condition that G₁₃ is not an alkanoyl group, an alkenoyl group or a benzoyl group, G₁₄ can also be a 1-oxo-(C₂-C₁₂)-alkylene group, a divalent radical of a dicarboxylic acid or of a dicarbamic acid, aliphatic, cycloaliphatic or aromatic, or also a —CO— group; or, when n is 1, G₁₃ and G₁₄ together can also be a divalent radical of a 1,2- or 1,3-dicarboxylic acid, aliphatic, cycloaliphatic or aromatic.

The term aryl refers to an aromatic hydrocarbon such as, for example, phenyl or naphthyl. The term aralkyl refers to an alkyl substituted with an aromatic hydrocarbon, for example, a hydrocarbon having from 6 to 10 carbon atoms; examples of aralkyls are benzyl, α-methylbenzyl, etc.

C₁-C₁₂ alkyl or C₁-C₁₈ alkyl groups have already been defined under point (a).

C₅-C₇ cycloalkyl groups are, preferably, cyclohexyl.

When G₁₃ is a C₇-C₈ aralkyl group, it is phenylethyl, preferably benzyl.

When G₁₃ is a C₂-C₅ hydroxyalkyl group, it is 2-hydroxyethyl, 2-hydroxypropyl, etc.

Examples of G₁₃, when it is a C₂-C₁₈ alkanoyl group, are: propionyl, butyryl, octanoyl, dodecanoyl, hexadecanoyl, octadecanoyl, etc., preferably acetyl and, when it is a C₃-C₅ alkenoyl group, preferably acryloyl.

Examples of G₁₄, when it is a C₂-C₈ alkenyl group, are: allyl, methallyl, 2-butenyl, 2-pentenyl, 2-hexenyl, 2-octenyl, etc.

Examples of G₁₄, when it is a C₁-C₄ alkyl group substituted by a hydroxyl, cyano, alkoxycarbonyl or carbamide group, are: 2-hydroxyethyl, 2-hydroxypropyl, 2-cyanoethyl, methoxycarbonylmethyl, 2-ethoxycarbonylethyl, 2-aminocarbonylpropyl, 2-(dimethylaminocarbonyl)ethyl, etc.

Examples of C₂-C₁₂ alkylene groups are: ethylene, propylene, 2,2-dimethylpropylene, tetramethylene, hexamethylene, octamethylene, decamethylene, dodecamethylene, etc.

Examples of C₆-C₁₅ arylene groups are: o- m- or p-phenylene, 1,4-naphthylene, 4,4′-diphenylene, etc.

Examples of C₆-C₁₂ cycloalkylene groups are, preferably, cyclohexylene.

Preferred compounds having general formula (VII) are those wherein n is 1 or 2, G is hydrogen, G₁₁ is hydrogen or methyl, G₁₃ is hydrogen, a C₁-C₁₂ alkyl group or a group having the formula:

and G₁₄, when n is 1, is hydrogen or a C₁-C₁₂ alkyl group and, when n is 2, is a C₂-C₈ alkylene group or a 1-oxo-₂-C₈ alkylene group.

Specific examples of polyalkylpiperidines having general formula (VII) are:

1) N,N′-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylene-1,6-diamine;

2) N,N′-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylene-1,6-diacetamide;

3) bis(2,2,6,6-tetramethylpiperidin-4-yl)amine;

4) 4-benzoylamino-2,2,6,6-tetramethylpiperidine;

5) N,N′-bis(2,2,6,6-tetramethylpiperidin-4-yl)-N,N′-dibutyladipamide;

6) N,N′-bis(2,2,6,6-tetramethylpiperidin-4-yl)-N,N′-dicyclohexyl-2-hydroxypropylene-1,3-diamine;

7) N,N′-bis(2,2,6,6-tetramethylpiperidin-4-yl)-p-xylylenediamine;

8) N,N′-bis(2,2,6,6-tetramethylpiperidin-4-yl)-succinediamide;

9) bis(2,2,6,6-tetramethylpiperidin-4-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-aminodipropionate;

10) compound having the formula:

11) 4-[bis(2- hydroxyethyl)amino]-1,2,2,6,6 -penta-methylpiperidine;

12) 4-(3-methyl-4-hydroxy-5-tert-butylbenzamido)-2,2,6,6-tetramethylpiperidine;

13) 4-methacrylamido-1,2,2,6,6-pentamethylpiperidine.

(c) Compounds Having General Formula (VIII):

 wherein n is 1 or 2; G, G₁ and G₁₁ have the same meanings desribed under point (a); G₁₅, when n is 1, is a C₂-C₈ alkylene or hydroxyalkylene group, or a C₄-C₂₂ acyloxyalkylene group, and, when n is 2, is a (—CH₂)₂C(CH₂—)₂ group.

Examples of G₁₅, when it is a C₂-C₈ alkylene or hydroxyalkylene group, are: ethylene, 1-methylethylene, propylene, 2-ethylpropylene, 2-ethyl-2-hydroxymethyl-propylene, etc.

An example of G₁₅, when it is a C₄-C₂₂ acyloxyalkylene group is 2-ethyl-2-acetoxymethylpropylene.

Specific examples of polyalkylpiperidines having general formula (VIII) are:

1) 9-aza-8,8,10,10-tetramethyl-1,5-dioxaspiro[5.5]undecane;

2) 9-aza-8,8,10,10-tetramethyl-3-ethyl-1,5-dioxa-spiro[5.5]undecane;

3) 8-aza-2,7,7,8,9,9-hexamethyl-1,4-dioxaspiro[4.5]-decane;

4) 9-aza-3-hydroxymethyl-3-ethyl-8,8,9,10,10-penta-methyl-1,5-dioxaspiro[5.5]undecane;

5) 9-aza-3-ethyl-3-acetoxymethyl-9-acetyl-8,8,10,10-tetramethyl-1,5-dioxaspiro[5.5]undecane;

6) 2,2,6,6-tetramethylpiperidine-4-spiro-2′-(1′,3′-dioxane)-5′-spiro-5″-(1″,3″-dioxane)-2″-spiro-4′″-(2′″,2′″,6′″,6′″-tetramethylpiperidine);

(d) Compounds having general formula (IXA), (IXB) and (IXC), the compounds having general formula (IXC) being preferred:

 wherein n is 1 or 2, G, G₁ and G₁₁ have the same meanings described under point (a); G₁₆ is hydrogen, a C₁-C₁₂ alkyl group, an allyl group, a benzyl, a glycidyl group or a C₂-C₆ alkoxyalkyl group; G₁₇, when n is 1, is hydrogen, a C₁-C₁₂ alkyl group, a C₃-C₅ alkenyl group, a C₇-C₉ aralalkyl group, a C₅-C₇ cycloalkyl group, a C₂-C₄ hydroxyalkyl group, a C₂-C₆ alkoxyalkyl group, a C₆-C₁₀ aryl group, a glycidyl group, or a group having the formula —(CH₂)_(p)—COO—Q or —(CH₂)_(p)—O—CO—Q wherein p is 1 or 2 and Q is a C₁-C₄ alkyl group or a phenyl; G₁₇, when n is 2, is a C₂-C₁₂ alkylene group, a C₄-C₁₂ alkenylene group, a C₆-C₁₂ arylene group, a group having the formula —CH₂—CH(OH)—CH₂—O—D—O—CH₂—CH(OH)—CH₂— wherein D is a C₂-C₁₀ alkylene group, a C₆-C₁₅ arylene group, a C₆-C₁₂ cycloalkylene group, or a group having the formula —CH₂CH(OZ′)CH₂—(OCH₂—CH(OZ′)CH₂)₂ wherein Z′ is hydrogen, a C₁-C₁₈ alkyl group, an allyl, a benzyl, a C₂-C₁₂ alkanoyl group or a benzoyl; T₁ and T₂ are, each independently, hydrogen, a C₁-C₁₈ alkyl group, a C₆-C₁₀ aryl group, a C₇-C₉ aralalkyl group, said groups optionally substituted with a halogen atom or with a C₁-C₄ alkyl group; or T₁ and T₂, considered jointly with the carbon atom to which they are bound, form a C₅-C₁₄ cycloalkane ring.

Examples of C₁-C₁₂ alkyl groups are: methyl, ethyl, n-propyl, n-butyl, sec-butyl, t-butyl, n-hexyl, n-octyl, 2-ethylhexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, etc.

Examples of C₁-C₁₈ alkyl groups are, in addition to those listed above: n-tridecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, etc.

Examples of C₂-C₆ alkoxyalkyl groups are: methoxymethyl, ethoxymethyl, propoxymethyl, t-butoxymethyl, ethoxyethyl, ethoxypropyl, n-butoxyethyl, t-butoxyethyl, isopropcxyethyl, propoxypropyl, etc.

Examples of G₁₇, when it is a C₃-C₅ alkenyl group are: 1-propenyl, allyl, methallyl, 2-butenyl, 2-pentenyl, etc.

Examples of G₁₇, T₁ and T₂, when they are a C₇-C₉ aralkyl group are: phenethyl, preferably benzyl.

Examples of cycloalkane rings, formed by T₁ and T2 when these substituents are considered jointly with the carbon atom to which they are bound, are: cyclopentane, cyclohexane, cyclo-octane, cyclododecane, etc.

Examples of G₁₇, when it is a C₂-C₄ hydroxyalkyl group, are: 2-hydroxyethyl, 2-hydroxypropyl, 2-hydroxybutyl, 4-hydroxybutyl, etc.

Examples of G₁₇, T₁ and T₂, when they are a C₆-C₁₀ aryl group are: α- or β-naphtyl, optionally substituted with a halogen atom or a C₁-C₄ alkyl group, etc.

Examples of G₁₇, when it is a C₂-C₁₂ alkylene group are, ethylene, propylene, 2,2-dimethylpropylene, tetramethylene, hexamethylene, octamethylene, decamethylene, dodecamethylene, etc.

Examples of G₁₇, when it is a C₄-C₁₂ alkenylene group are: 2-butenylene, 2-pentenylene, 3-hexenylene, etc.

Examples of G₁₇, when it is a C₆-C₁₂ arylene group are: o-, m- or p-phenylene, 1,4-naphthylene, 4,4′-di-phenylene, etc.

Examples of Z′, when it is a C₂-C₁₂ alkanoyl group are: propionyl, butyryl, octanoyl, dodecanoyl, preferably acetyl.

Examples of D, when it is a C₂-C₁₀ alkylene group, a C₆-C₁₅ arylene group or a C₆-C₁₂ cycloalkylene group are defined above under point (b).

Specific examples of polyalkylpiperidines having general formula (IX) are:

1) 3-benzyl-1,3,8-triaza-7,7,9,9-tetramethylspiro-[4.5]decane-2,4-dione;

2) 3-n-octyl-1,3,8-triaza-7,7,9,9-tetramethylspiro-[4.5]decane-2,4-dione;

3) 3-allyl-1,3,8-triaza-1,7,7,9,9-pentamethylspiro-[4.5]decane-2,4-dione;

4) 3-glycidyl-1,3,8-triaza-7,7,8,9,9-pentamethyl-spiro[4.5]decane-2,4-dione;

5) 1,3,7,7,8,9,9-heptamethyl-1,3,8-triazaspiro[4.5]-decane-2,4-dione;

6) 2-isopropyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane;

7) 2,2-dibutyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane;

8) 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-oxodi-spiro[5.1.11.2]heneicosane;

9) 2-butyl-7,7,9,9-tetramethyl-1-oxa-4,8-diaza-3-oxospiro[4.5]decane; and, preferably,

10) 8-acetyl-3-dodecyl-1,3,8-triaza-7,7,9,9-tetra-methylspiro[4.5]decane-2,4-dione;

or a compound having one of the following formulae:

(e) Compounds Having General Formula (X):

 wherein n is 1 or 2, and G₁₈ is a group having one of the following formulae:

 wherein G and G₁₁ have the same meanings described under point (a); G₁ and G₂ are hydrogen, methyl, or together form a substituent ═O, E is —O— or —NG₁₃—; A is a C₂--C₆ alkylene group or a —(CH₂)₃—O— group; x is 0 or 1; G₁₃ is hydrogen, a C₁-C₁₂ alkyl group, a C₂-C₅ hydroxyalkyl group, a C₅-C₇ cycloalkyl group; G₁₉ has the same meanings as G₁₈ or is one of the following groups: —NG₂₁G₂₂, —OG₂₃, —NHCH₂OG₂₃ or —N(CH₂OG₂₃)₂; G₂₀, when n is 1, has the same meanings as G₁₈ or G₁₉ and, if n is 2, it is an —E—B—E— group wherein B is a C₂-C₈ alkylene group optionally interrupted by 1 or 2 —N(G₂₁)— groups; G₂₁ is a C₁-C₁₂ alkyl group, a cyclohexyl group, a benzyl, a C₁-C₄ hydroxyalkyl group, or a group having the following general formula:

 G₂₂ is a C₁-C₁₂ alkyl group, a cyclohexyl group, a benzyl, a C₁-C₄ hydroxyalkyl group; G₂₃ is hydrogen, a C₁-C₁₂ alkyl group, a phenyl, or G₂₁ and G₂₂ together are a C₄-C₅ alkylene or oxyalkylene group, for example:

 or a group having the formula:

 G₂₁ is a group having the general formula:

Examples of C₁-C₁₂ alkyl groups are: methyl, ethyl, n-propyl, n-butyl, sec-butyl, t-butyl, n-hexyl, n-octyl, 2-ethylhexyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, etc.

Examples of C₁-C₄ hydroxyalkyl groups are: 2-hydroxyethyl, 2-hydroxypropyl, 3-hydroxypropyl, 2-hydroxybutyl, 4-hydroxybutyl, etc.

Examples of A, when it is a C₂-C₆ alkylene group are: ethylene, propylene, 2,2-dimethylpropylene, tetramethylene, hexamethylene, etc.

Examples of G₂₁ and G₂₂, when they jointly form a C₄-C₅ alkylene or oxyalkylene group, are: tetramethylene, pentamehylene, 3-oxapentamethylene, etc.

Specific examples of polyalkylpiperidines having general formula (X) are:

(f) Oligomeric or polymeric compounds whose recurrent structural unit contains a 2,2,6,6tetramethyl-piperidine radical having general formula (V), in particular polyesters, polyethers, polyamides, polyamines, polyurethanes, polyureas, polyamino-triazines, poly(meth)acrylates, poly(meth)acrylamides, and their copolymers containing said radical.

Specific examples of the above 2,2,6,6-polyalkyl-piperidines are represented by the following formulae wherein m is a number between 2 and 200:

wherein m′ and m″ are an integer between 0 and 200 extremes included, on the condition that m′+m″ is m.

Further examples of light stabilizers which can be used for the purpose are:

the reaction products between compounds having formula (XII):

 and epichlorohydrin;

polyesters obtained by the reaction of butane-1,2,3,4-tetracarboxylic acid with a bifunctional alcohol having formula (XIII):

 whose carboxylic termination generated by tetracaboxylic acid has been esterified with a 2,2,-6,6-tetramethyl-4-hydroxypiperidine group;

compounds having general formula (XIV);

 wherein about a third of the R radicals represent a —C₂H₅ group and the remaining a group having the formula:

 and m is a number between 2 and 200 extremes included;

copolymers whose recurrent unit consists of two units having the formula:

 a unit having the formula:

 and a unit having the formula:

(g) Compounds having general formula (XVIII):

 wherein G, G₁ and G₁₁ have the same meanings described above under point (a). Compounds having general formula (XVIII) wherein G is hydrogen and G₁₁ is hydrogen or methyl, are preferably used.

Specific examples of compounds having general formula (XVIII) are:

2,2,6,6-tetramethyl-4-piperidone (triacetone-amine);

2,2,6,6-pentamethyl-4-piperidone;

2,3,6-trimethyl-2,6-diethyl-4-piperidone.

(h) Compounds having general formula (XIX):

 wherein G₁₁ has the same meanings described above under point (a) and G₂₅ is a direct bond, a methylene or preferably a carbonyl, as described in German patent application DE 3,530,666.

(i) Compounds having general formula (XX):

 wherein R₁ is a C₁-C₁₀ alkyl group, a C₅-C₁₂ cycloalkyl group optionally substituted with a C₁-C₄ alkyl group, a phenyl optionally substituted with a C₁-C₁₀ alkyl group; R₂ is a C₃-C₁₀ alkylene group; R₃ is a hydrogen, a C₁-C₈ alkyl group, O⁺, a —CH₂CN group, a C₃-C₆ alkenyl group, a C₇-C₉ phenylalkyl group optionally substituted in the phenyl radical with a C₁-C₄ alkyl group, a C₁-C₈ acyl group; and n₁ is a number between 1 and 50 extremes included.

Specific examples of compounds having general formula (XX) are:

(1) poly-methylpropyl-3-oxy-[4-(2,2,6,6-tetramethyl)-piperidinyl]siloxane, known under the trade-name of UVASIL 299 of Great Lakes;

(2) poly-methylpropyl-3-oxy-[4-(1,2,2,6,6-penta-methyl)-piperidinyl]siloxane.

The crystalline modification of the present invention can be combined, as specified above, with other conventional additives or their mixtures. These additives are added in a quantity ranging from about 0.1% to 5% by weight with respect to the weight of the films based on polyolefins or polyolefinic copolymers to be stabilized, preferably between 0.5% and about 3% by weight.

Examples of other conventional additives which can be used are: antioxidants (such as, for example, alkylated monophenols, alkylthiomethylphenols, hydroquinones and alkylated hydroquinones, tocopherols, hydroxylated thiophenyl ethers, alkylidene-bisphenols, benzyl compounds containing O, N or S, hydroxybenzylated malonates, aromatic hydroxybenzyl compounds, triazine compounds, benzylphosphonates, acylaminophenols, esters of β-(3,5-di-t-butyl-4-hydroxyphenyl)propionic acid with monohydric or polyhydric alcohols, esters of β-(5-t-butyl-4-hydroxyphenyl)propionic acid with monohydric or polyhydric alcohols, esters of β-(3,5-dicyclohexyl-4-hydroxyphenyl)propionic acid with monohydric or polyhydric alcohols, esters of (3,5-di-t-butyl-4-hydroxyphenyl)acetic acid with monohydric or polyhydric alcohols, amides of β-(3,5-di-t-butyl-4-hydroxyphenyl)-propionic acid; other ultraviolet-ray and light stabilizers (such as, for example, derivatives of 2-(2′-hydroxyphenyl)benzotriazoles, esters of benzoic acids, acrylates, oxamides, 2-(2-hydroxyphenyl)-1,3,5-triazine); “metal deactivators”; phosphites and phosphonites; agents capable of destroying peroxides; basic costabilizers, nucleating agents; fillers and reinforcing agents; other additives (such as, for example, plasticizers, emulsifying agents, pigments, optical brighteners, flame-retardants, antistatic agents, blowing agents, thiosynergizing agents); benzofuranones and indolinones.

The present invention also relates to a process for the stabilization of agricultural films based on polyolefins or polyolefinic copolymers, particularly useful for greenhouses, comprising the incorporation of the crystalline modification of the present invention into the polyolefins or polyolefinic copolymers subsequently transformed into the above films. Greenhouses covered with the above agricultural films are a further object of the present invention.

Some illustrative but non-limiting examples are provided hereunder for a better understanding of the present invention and for its embodiment.

EXAMPLE 1

2.5 kg of [2,2′-thiobis(4-octylphenolate)-n-butylamine Nickel II] in powder form and 2.5 kg of 2-hydroxy-4-n-octyloxybenzophenone in powder form, are mixed and subsequently fed to a Maris corotating twin-screw extruder 33/40 (screws with a diameter of 33 mm and a length of 40 diameters).

The operating conditions are the following:

Screw rate: 100 r.p.m.

Temperature of the nine extruder zones: 40/30/40/30/40/35/35/40/51° C.

Diameter of the die holes: 2.5 mm.

The product leaves the die in the form of a solid “spaghettol” which, after cooling with air at room temperature, is fragmented into granules having a diameter of 2.5 mm and a length ranging from 0.5 to 5 mm.

The product thus obtained has a melting range (in capillary) of 46° C.-188° C. and an X-Ray diffraction spectrum from powders indicated in FIG. 4.

EXAMPLE 2

Light Resistance of Polyethylene Films

500 g of low density polyethylene (Riblene FC20 of Polimeri Europa) are mixed with the following additives:

(A) a mixture of nickel-quencher (a) and benzophenone (b) powders in a ratio 1:1;

(B) granules obtained by extrusion as described in Example 1; at the following concentrations: 0.25%, 0.50% and 0.75% by weight.

Each mixture is charged into a 3Brabender PL2000 single-screw extruder with a diameter of 19 mm, a length about 25 times the diameter, equipped with a screw and nozzle of 2 mm.

The operating conditions are the following:

screw rate: 60 r.p.m.

temperature of the extruder: 190° C.-200° C.-220° C.-220° C.

The product leaves the die in the form of a solid “spaghetto” which, after cooling with water, is fragmented into granules.

The polymer granules obtained as described above, are extruded again using a Plasticizer operating at a temperature of 190° C.-200° C.-220° C.-220° C.-220° C., obtaining films having a thickness of 170 μm.

The films thus obtained are subjected to accelerated aging in a Xenon Arc Weatherometer (WOM) under the following operating conditions:

temperature of the black panel: 60° C.;

irradiation: 0.33 w/m²

relative humidity: 50%.

The films are removed from the irradiation chamber at regular intervals and subjected to tensile stress, measuring the elongation at breaking which is obviously reduced during the period of exposure in the weatherometer.

t 50% was adopted as evaluation criterium of the properties of the additives, i.e. the exposure time of the films to radiation in the weathometer necessary for obtaining a 50% reduction n the original elongation at breaking.

Considering that the effectiveness of the light stabilizing additive used, at the same concentration, is in direct correlation with t 50%, FIG. 5 demonstrates that the crystalline modification of the present invention, gives polyethylene films a better stabilization with respect to the mixture of powders. 

What is claimed is:
 1. A crystalline form of a mixture comprising: (a) a nickel-quencher having the chemical name [2,2′-thiobis(4-t-octyl-phenolate)-n-butylamine Nickel (II)], and the formula (I):

(b) a 2-hydroxy-4-alkyloxybenzophenone having the chemical name 2-hydroxy-4-n-octyloxybenzophenone, and the formula (II):

 characterized in that said mixture has two diffraction lines at angles 2θ=6.291 and 2θ=6.888 in the X-Ray diffraction spectrum determined from a sample in powder form.
 2. The crystalline form of a mixture according to claim 1, wherein said nickel-quencher (a) having formula (I) and said benzophenone (b) having formula (II), are used in a ratio ranging from 0.4 to
 3. 3. The crystalline form of a mixture according to claim 2, wherein said nickel-quencher (a) having formula (I) and said benzophenone (b) having formula (II), are used in a ratio ranging form 1 to
 2. 4. A process for the preparation of the crystalline form of a mixture according to any of the previous claims, comprising the extrusion of a mixture of said components (a) and (b) in powder form operating at such a temperature that only a small part of said benzophenone (b), having a melting point of 47° C.-50°, melts and dissolves only a small part of said nickel-quencher (a), having a melting point of 260°, obtaining a solid “spaghetto”.
 5. The process according to claim 4, wherein the solid “spaghetto”, after appropriate cooling, is granulated by cutting at the head of the extruder or by subsequent fragmentation.
 6. Agricultural films based on polyolefins or polyolefinic copolymers, containing said crystalline form of a mixture according to claims 1, 2 or 3 in a quantity sufficient to achieve light stabilization.
 7. The agricultural films according to claim 6, wherein any of the oxides or hydroxides of zinc, aluminum or calcium, magnesium oxide, salts of alkaline earth metals, zinc salts and aluminum salts of a C₁-C₃₀ carboxylic acid, hydrotalcites, and sterically hindered amines, are present.
 8. A process for the stabilization of agricultural films based on polyolefins or polyolefinic copolymers, comprising the incorporation of the crystalline form of the mixture according to any of the claims from 1 to 3, into the polyolefins or polyolefinic copolymers subsequently transformed into the above films.
 9. Greenhouses covered with the agricultural films according to claim
 6. 